Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.510
+0.040 (2.72%)
At close: Aug 13, 2025, 4:00 PM
1.500
-0.010 (-0.66%)
After-hours: Aug 13, 2025, 6:44 PM EDT
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $728.87K in the quarter ending March 31, 2025, a decrease of -11.52%. This brings the company's revenue in the last twelve months to $2.94M, up 3.87% year-over-year. In the fiscal year ending June 30, 2024, Intelligent Bio Solutions had annual revenue of $3.11M with 147.58% growth.
Revenue (ttm)
$2.94M
Revenue Growth
+3.87%
P/S Ratio
2.14
Revenue / Employee
$58,729
Employees
50
Market Cap
10.43M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
INBS News
- 1 day ago - Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 - GlobeNewsWire
- 6 days ago - Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum - GlobeNewsWire
- 7 days ago - Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch - GlobeNewsWire
- 14 days ago - Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator - GlobeNewsWire
- 19 days ago - Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds - GlobeNewsWire
- 21 days ago - Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing - GlobeNewsWire